Distribution of amantadine-resistant H5N1 avian influenza variants in Asia

Journal of Infectious Diseases

Volumn 193, Issue 12, 2006, Pages 1626-1629

  Cheung, Chung Lam ^a   Rayner, Jane M ^a,b   Smith, Gavin J D ^a,b   Wang, Pui ^a   Naipospos, T S P ^d   Zhang, Jinxia ^a,b   Yuen, Kwok Yung ^a   Webster, Robert G ^a,c   Peiris, J S Malik ^a,b   Guan, Yi ^a,b,e   Chen, Honglin ^a,b,e  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d Center for Indonesian Veterinary Analytical Studies   (Indonesia)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ASPARAGINE; ISOLEUCINE; LEUCINE; RIMANTADINE; SERINE;

ARTICLE; ASIA; CAMBODIA; CHINA; GENE MUTATION; HONG KONG; INDONESIA; INFLUENZA VIRUS; INFLUENZA VIRUS A H5N1; PRIORITY JOURNAL; PROTEIN MOTIF; THAILAND; VIET NAM; VIRUS ISOLATION;

AMANTADINE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIVIRAL AGENTS; ASIA; BIRDS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; RIMANTADINE;

EID: 33744786760     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/504723     Document Type: Article

References (16)

1. World Organization for Animal Health. Update on avian influenza in animals (type H5) (27 April 2006). Available at: http://www.oie.int/ downld/AVIAN%20INFLUENZA/A_AI-Asia.htm. Accessed 3 May 2006.
2. Chen H, Smith GJD, Li KS, et al. Establishment of multiple sub-lineages of H5N1 influenza virus in Asia-implications for pandemic control. Proc Natl Acad Sci 2006; 103:2845-50.
3. World Health Organization Global Influenza Program Surveillance Network. Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis 2005; 11:1515-21.
4. World Health Organization. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO (25 January 2006). Available at: http://www.who.int/csr/disease/avian_influenza/country/ cases_table_2006_01_25/ en/index.html. Accessed 3 May 2006.
5. Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005;353:1374-85.
6. Webster R, Hulse D. Controlling avian flu at the source. Nature 2005; 435:415-6.
7. De Clercq E. Recent highlights in the development of new antiviral drugs. Curr Opin Microbiol 2005;8:552-60.
8. Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989; 321:1696-702.
9. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006; 295:891-4.
10. Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004; 430:209-13.
11. Macken C, Lu H, Goodman J, Boykin L. The value of a database in surveillance and vaccine selection. In: Osterhaus ADME, Cox N, Hampson AW, eds. Options for the control of influenza IV. Amsterdam: Elsevier Science, 2001:103-6.
12. Scholtissek C, Quack G, Klenk HD, Webster RG. How to overcome resistance of influenza A viruses against adamantane derivatives. Antiviral Res 1998; 37:83-95.
13. Bright RA, Medina MJ, Xu X, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005; 366:1175-81.
14. Astrahan P, Kass I, Cooper MA, Arkin IT. A novel method of resistance for influenza against a channel-blocking antiviral drug. Proteins 2004; 55:251-7.
15. Monto AS, Gunn RA, Bandyk MG, King CL. Prevention of Russian influenza by amantadine. JAMA 1979; 241:1003-7.
16. Marozin S, Gregory V, Cameron K, et al. Antigenic and genetic diversity among swine influenza A H1N1 and H1N2 viruses in Europe. J Gen Virol 2002; 83:735-45.